Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-024438-52Phase 4Terminated
Phase 4, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Prednisone with Placebo (2 arms). Primary endpoint: Primary efficacy of prednisone vs placebo on olfactory function. Started Aug 2011; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-024438-52.